VWF and von Willebrand disease (hereditary or acquired): Another limitation of the study is that most of the patients (80%) were Caucasian, which may not necessarily reflect VWF pharmacokinetics and clinical outcomes across all patients with VWD given the known variation in VWF levels according to race/ethnicity.